Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

SHSE:688336 株式レポート

時価総額:CN¥14.1b

Sunshine Guojian Pharmaceutical (Shanghai) マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間4.3yrs

経営陣の近況

Recent updates

Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet

Nov 19
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Has A Rock Solid Balance Sheet

Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 29
Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump

Oct 01
There's Reason For Concern Over Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) Massive 30% Price Jump

What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You

Jul 25
What Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd's (SHSE:688336) P/E Is Not Telling You

Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?

Jun 20
Is Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) A Risky Investment?

If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity

May 24
If EPS Growth Is Important To You, Sunshine Guojian Pharmaceutical (Shanghai) (SHSE:688336) Presents An Opportunity

We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings

Mar 31
We Think That There Are Issues Underlying Sunshine Guojian Pharmaceutical (Shanghai)'s (SHSE:688336) Earnings

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 04
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHSE:688336) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

CEO(最高経営責任者

Sunshine Guojian Pharmaceutical (Shanghai) CEOがいない、あるいは彼らに関するデータがない。


取締役

名称ポジション在職期間報酬所有権
Dongmei Su
Director2.2yrsデータなしデータなし
Jing Lou
Chairman of the Board8.7yrsCN¥993.10k4.08%
CN¥ 573.4m
Wei Zhang
Independent Director5.3yrsCN¥136.80kデータなし
Yongli Jin
Independent Director5.3yrsCN¥136.80kデータなし
Fanzhi Huang
Independent Director3.4yrsCN¥136.80kデータなし
Jing Wu
Employee Representative Supervisor3.2yrsデータなしデータなし

4.3yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: 688336の 取締役会経験豊富 であると考えられます ( 4.3年の平均在任期間)。